Clinical Trial Update: Preoperative Bevacizumab and Trastuzumab With ABI-007 and Carboplatin in HER2+ Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating preoperative bevacizumab and trastuzumab with ABI-007 (nab-paclitaxel) and carboplatin in HER2-positive breast cancer; results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• Avastin (bevacizumab)
• CARBOPLATIN (Carboplatin)
• HERCEPTIN (trastuzumab)

Snippet

Sponsor: SCRI Development Innovations, LLC | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2013-02-13